SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-069340
Filing Date
2024-06-05
Accepted
2024-06-05 16:22:18
Documents
6
Effectiveness Date
2024-06-05

Document Format Files

Seq Description Document Type Size
1 S-8 xene-2024-s-8_share_rese.htm S-8 139832
2 EX-5.1 xene-ex5_1.htm EX-5.1 9991
3 EX-23.1 xene-ex23_1.htm EX-23.1 5703
4 EX-FILING FEES xene-exfiling_fees.htm EX-FILING FEES 18471
5 GRAPHIC img3998686_0.jpg GRAPHIC 13515
6 GRAPHIC img3998686_1.jpg GRAPHIC 26886
  Complete submission text file 0000950170-24-069340.txt   230962
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279962 | Film No.: 241022283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)